421 related articles for article (PubMed ID: 21784100)
1. Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia.
Suzuki Y; Suda T; Yokomura K; Suzuki M; Fujie M; Furuhashi K; Hahimoto D; Enomto N; Fujisawa T; Nakamura Y; Inui N; Nakano Y; Nakamura H; Chida K
J Infect; 2011 Sep; 63(3):215-22. PubMed ID: 21784100
[TBL] [Abstract][Full Text] [Related]
2. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
[TBL] [Abstract][Full Text] [Related]
3. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
4. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients.
Huttunen R; Syrjänen J; Aittoniemi J; Oja SS; Raitala A; Laine J; Pertovaara M; Vuento R; Huhtala H; Hurme M
Shock; 2010 Feb; 33(2):149-54. PubMed ID: 19487973
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.
Ploder M; Spittler A; Schroecksnadel K; Neurauter G; Pelinka LE; Roth E; Fuchs D
Clin Sci (Lond); 2009 Apr; 116(7):593-8. PubMed ID: 18986303
[TBL] [Abstract][Full Text] [Related]
6. Activation of the tryptophan/serotonin pathway is associated with severity and predicts outcomes in pneumonia: results of a long-term cohort study.
Meier MA; Ottiger M; Vögeli A; Steuer C; Bernasconi L; Thomann R; Christ-Crain M; Henzen C; Hoess C; Zimmerli W; Huber A; Mueller B; Schuetz P
Clin Chem Lab Med; 2017 Jun; 55(7):1060-1069. PubMed ID: 28076309
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric measurement of urinary kynurenine-to-tryptophan ratio in children with and without urinary tract infection.
Yarbrough ML; Briden KE; Mitsios JV; Weindel AL; Terrill CM; Hunstad DA; Dietzen DJ
Clin Biochem; 2018 Jun; 56():83-88. PubMed ID: 29679555
[TBL] [Abstract][Full Text] [Related]
8. Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer.
de Jong RA; Nijman HW; Boezen HM; Volmer M; Ten Hoor KA; Krijnen J; van der Zee AG; Hollema H; Kema IP
Int J Gynecol Cancer; 2011 Oct; 21(7):1320-7. PubMed ID: 21720257
[TBL] [Abstract][Full Text] [Related]
9. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W
Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957
[TBL] [Abstract][Full Text] [Related]
10. Activation of the kynurenine pathway is associated with poor outcome in Pneumocystis pneumonia patients infected with HIV: results of 2 months cohort study.
Wang M; Dong X; Huang Y; Su J; Dai X; Guo Y; Hu C; Zhou Q; Zhu B
BMC Infect Dis; 2019 Mar; 19(1):223. PubMed ID: 30832615
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome.
Pertovaara M; Raitala A; Uusitalo H; Pukander J; Helin H; Oja SS; Hurme M
Clin Exp Immunol; 2005 Oct; 142(1):155-61. PubMed ID: 16178870
[TBL] [Abstract][Full Text] [Related]
12. Low indoleamine 2,3-dioxygenase activity in persistent food allergy in children.
Buyuktiryaki B; Sahiner UM; Girgin G; Birben E; Soyer OU; Cavkaytar O; Cetin C; Arik Yilmaz E; Yavuz ST; Kalayci O; Baydar T; Sackesen C
Allergy; 2016 Feb; 71(2):258-66. PubMed ID: 26449488
[TBL] [Abstract][Full Text] [Related]
13. Serum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosis.
Suzuki Y; Suda T; Asada K; Miwa S; Suzuki M; Fujie M; Furuhashi K; Nakamura Y; Inui N; Shirai T; Hayakawa H; Nakamura H; Chida K
Clin Vaccine Immunol; 2012 Mar; 19(3):436-42. PubMed ID: 22219312
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season.
Pertovaara M; Hasan T; Raitala A; Oja SS; Yli-Kerttula U; Korpela M; Hurme M
Clin Exp Immunol; 2007 Nov; 150(2):274-8. PubMed ID: 17711489
[TBL] [Abstract][Full Text] [Related]
15. [Indoleamine 2, 3-dioxygenasase (IDO) as a prognostic factor of hematological malignancies].
Hara T; Tsurumi H
Rinsho Byori; 2011 Dec; 59(12):1133-43. PubMed ID: 22338916
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality.
Pertovaara M; Raitala A; Lehtimäki T; Karhunen PJ; Oja SS; Jylhä M; Hervonen A; Hurme M
Mech Ageing Dev; 2006 May; 127(5):497-9. PubMed ID: 16513157
[TBL] [Abstract][Full Text] [Related]
17. Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients.
Kato A; Suzuki Y; Suda T; Suzuki M; Fujie M; Takita T; Furuhashi M; Maruyama Y; Chida K; Hishida A
Hemodial Int; 2010 Oct; 14(4):418-24. PubMed ID: 20673309
[TBL] [Abstract][Full Text] [Related]
18. [Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer].
Sakurai K; Matsuo S; Enomoto K; Tani M; Kitajima A; Amano S
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1991-3. PubMed ID: 20037301
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.
Brandacher G; Cakar F; Winkler C; Schneeberger S; Obrist P; Bösmüller C; Werner-Felmayer G; Werner ER; Bonatti H; Margreiter R; Fuchs D
Kidney Int; 2007 Jan; 71(1):60-7. PubMed ID: 17136028
[TBL] [Abstract][Full Text] [Related]
20. Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
Botticelli A; Cerbelli B; Lionetto L; Zizzari I; Salati M; Pisano A; Federica M; Simmaco M; Nuti M; Marchetti P
J Transl Med; 2018 Aug; 16(1):219. PubMed ID: 30081936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
